npr semaglutide Medicare launches weight loss drug option with $50 copay : Cheaper semaglutide alternatives to Wegovy
Description
Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC, and because there are alternative semaglutide products that do not contain SNAC that can be used during lactation, advise patients that breastfeeding is not recommended during treatment with RYBELSUS or OZEMPIC tablets

The largest body of evidence supports GLP-1 monotherapy as the first-line pharmacological approach for weight loss in eligible patients, with semaglutide and tirzepatide demonstrating sustained weight reductions of 15 to 22 percent of baseline body weight

As a result, the face can look older or more tired than expected

Its dramatic effects on their lives is a sharp reminder that GLP-1 agonists are not the whole story of obesity
